Quick Answer
Alaunos Therapeutics, Inc. reported Common Stock Shares Outstanding of 2.35 million shares for the year ending 2025.
- Alaunos Therapeutics, Inc. showed an increase of +46.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Alaunos Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), Alaunos Therapeutics, Inc.'s Common Stock Shares Outstanding has declined by 95.2%.
- Historical annual values: Fiscal year 2025: 2.35 million shares | Fiscal year 2024: 1.60 million shares | Fiscal year 2023: 1.60 million shares | Fiscal year 2022: 16.03 million shares | Fiscal year 2021: 216.13 million shares | Fiscal year 2020: 214.59 million shares | Fiscal year 2019: 181.80 million shares | Fiscal year 2018: 161.07 million shares | Fiscal year 2017: 142.66 million shares | Fiscal year 2016: 132.38 million shares | Fiscal year 2015: 131.72 million shares | Fiscal year 2014: 104.45 million shares | Fiscal year 2013: 100.16 million shares | Fiscal year 2012: 83.24 million shares | Fiscal year 2011: 69.21 million shares | Fiscal year 2010: 48.47 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: